Showing results (21-30 of 2,167) with videos related to

Sort By:
Pageof 217
European Urology|December 26, 2001
Diagnosis and monitoring of urological tumors using positron emission tomographyC Hofer, H Kübler, R Hartung, et al.
BJU International|December 21, 2000
Limited value of endorectal magnetic resonance imaging and transrectal ultrasonography in the staging of clinically localized prostate cancerF May, T Treumann, P Dettmar, et al.
Der Urologe. Ausg. A|November 13, 2002
[Significance of endorectal nuclear magnetic resonance tomography and transrectal ultrasound diagnosis in local staging of prostatic carcinoma]F May, T Treumann, P Dettmar, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 27, 1998
[Probability of seminal vesicle involvement in localized prostatic carcinoma. Significance in conformal radiotherapy]H J Feldmann, J Breul, F Zimmermann, et al.
The Journal of Gene Medicine|May 22, 2007
Allogeneic retrovirally transduced, IL-2- and IFN-gamma-secreting cancer cell vaccine in patients with hormone refractory prostate cancer--a phase I clinical trialT H Brill, H R Kübler, H von Randenborgh, et al.
European Urology|January 1, 1997
5-Fluorouracil versus folinic acid and 5-fluorouracil in advanced, hormone-resistant prostate cancer: a prospective randomized pilot trialJ Breul, G Jakse, G Forster, et al.
Urologia Internationalis|April 27, 2000
Value of free prostate-specific antigen (Hybritech Tandem-R) in symptomatic patients consulting the urologistC Hofer, P Sauerstein, C Wolter, et al.
European Urology|June 12, 1999
Fluorine-18-fluorodeoxyglucose positron emission tomography is useless for the detection of local recurrence after radical prostatectomyC Hofer, C Laubenbacher, T Block, et al.
World Journal of Surgery|November 9, 2000
New ultradeformable drug carriers for potential transdermal application of interleukin-2 and interferon-alpha: theoretic and practical aspectsC Hofer, R Hartung, R Göbel, et al.
Analytical Cellular Pathology : the Journal of the European Society for Analytical Cellular Pathology|August 1, 1994
High resolution image-cytometric differentiation of hormone sensitive and hormone insensitive prostatic carcinomasU Schenck, G Burger, U Jütting, et al.
Pageof 217